# FDA recall D-0202-2025

> **Amerisource Health Services LLC** · Class II · drug recall initiated 2024-12-17.

## Product

glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11

## Reason for recall

Failed Dissolution Specifications:

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0202-2025
- **Recalling firm:** Amerisource Health Services LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2024-12-17
- **Report date:** 2025-01-22
- **Termination date:** 2026-04-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Columbus, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0202-2025

## Citation

> AI Analytics. FDA recall D-0202-2025. Retrieved 2026-06-05 from https://api.ai-analytics.org/recall/D-0202-2025. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*